Login to Your Account

Other News To Note

Tuesday, August 6, 2013
• Aerpio Therapeutics Inc., of Cincinnati, said collaborators from Massachusetts General Hospital, Harvard Medical School, New York University and the Massachusetts Institute of Technology published data on its Tie2 activator, AKB-9778, in the Journal of the National Cancer Institute.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription